This is an automated archive made by the Lemmit Bot.

The original was posted on /r/singularity by /u/Anen-o-me on 2024-09-24 04:36:26+00:00.

Original Title: New partial reprogramming result from Altos Labs: the Belmonte group reports a ~12% lifespan increase (equivalent to a ~38% increase in remaining lifespan after the start of therapy at 18 months) in normal mice via a Cdkn2a-OSK gene therapy: